Form 4: Corvus Pharmaceuticals CEO Richard Miller Reports Acquisition of Shares and Warrants
SEC Form 4 Filing
Richard Miller, CEO of Corvus Pharmaceuticals, reports acquiring shares and warrants of the company's common stock.
Summary
- Richard A. Miller, the President and CEO of Corvus Pharmaceuticals, reported changes in his beneficial ownership of the company's securities on May 6, 2024.
- Miller acquired 577,634 shares of common stock at a price of $1.7312 per share.
- He also acquired 559,073 warrants, each representing the right to buy one share of common stock at an exercise price of $3.50, expiring on June 30, 2025.
- Following these transactions, Miller directly owns 559,073 derivative securities and indirectly owns 1,490,119 shares through the Miller-Horning Family Trust.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard SEC filing detailing insider transactions. The CEO's purchase is a potentially positive signal, but the filing itself is factual.
Positives
- The CEO's purchase of shares and warrants could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders of a publicly traded company buy or sell the company's securities. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.
Stakeholder Impact
- Shareholders may view the CEO's purchase of shares and warrants as a positive signal.
Key Dates
| Date | Description |
|---|---|
| January 25, 1985 | Date of Miller-Horning Family Trust agreement |
| May 06, 2024 | Date of transaction: acquisition of shares and warrants |
| May 07, 2024 | Date of signature on the Form 4 filing |
| June 30, 2025 | Expiration date of the warrants |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.